Merck Company Foundation: Grants for Diseases

OVERVIEW: The Merck Company Foundation’s United States grantmaking funds causes related to cancer, hepatitis C, diabetes and HIV/AIDS.

IP TAKE: Although its requirements are very strict, Merck accepts full proposals without a letter of inquiry.

PROFILE: The Merck Company Foundation is the philanthropic arm of Merck & Co., one of the largest pharmaceutical companies in the world. It invests in projects intended to enhance health, education and community well-being, both in the United States and abroad. The foundation's stated goal is to "improve health care quality and health system capacity as well as increase access to care for underserved populations." Currently, its two main focus areas are Health and Community.

Merck’s Health funding primarily aims to support programs with a proven record of “advancing the quality of health services delivery,” “reducing health care disparities,” “fostering innovation in the delivery of health care,” and “empowering patients as active participants in managing their own health.” It prioritizes “specific health challenges that have relevance to our company,” such as Alzheimer’s disease, cancer, diabetes, and HIV/AIDS. Past grantees include the YMCA Diabetes Prevention Program, Healthpartners Center for Memory and Aging, and the American Cancer Society.

The Merck Company Foundation’s grants generally fall between $5,000 and $500,000. Grantseekers may review its Annual Reports for more information on its grantmaking habits.

Merck accepts applications in full throughout the year. Note that in the United States it prioritizes organizations based in California, Delaware, Illinois, Massachusetts, Maryland, New Jersey, New York, North Carolina, Pennsylvania, Tennessee, Texas, Virginia, Wyoming and the District of Columbia.


Search for staff contact info and bios in PeopleFinder (paid subscribers only).